Title: seeta123 (1)
1Global Amblyopia Market By Treatments (Atropine
Drops, Eye Patches,
Glasses, Video Game, and Others), By End-users
(Ophthalmic Clinics,
Hospitals Pharmacies and Others), By Diagnosis
(Visual Acuity Tests, Photo
Screening, Brückner Test, and Others), By Types
(Strabismus Amblyopia,
Refractive Amblyopia, Deprivation Amblyopia,
Reverse Amblyopia, and
Others) and By Regions (North America, Europe,
Asia Paci c, Latin America
and Middle East Africa)
2Market Outlook
- The global amblyopia market was valued at USD
4,608.2 Million in 2019 and is projected to reach
US 6,203.6 Million by 2027, expanding at a CAGR
of 4.0 during the forecast period. Amblyopia
occurs in early childhood when the brain favors
only one of the eye due to improper stimulation
between the brain and an eye nerve pathway.
3(No Transcript)
4Market Dynamics
- The market is driven by factors such as
increasing cases of ophthalmological disorders
including refractive errors and cataracts across
the globe. Moreover, favorable government funding
for ophthalmology research is boosting market
growth in developing countries such as India,
Mexico, and China. Increasing demand for glasses
and eye patches at economic costs is fueling
growth of the global amblyopia market. Rising
treatments pertaining to amblyopia has now
extended beyond patching for youngsters and
adults to help patients of any ages to get rid of
diseases in the present scenario. Thus, consumers
are now encouraged to avail for amblyopia
treatments around the world.
5Segmental Outlook
- On the basis of treatment, the Global Amblyopia
Market has been segmented into eye patches,
atropine drops, glasses, video game, and others.
The video game treatment segment is anticipated
to expand at a CAGR of around 4.1 during the
forecast period due to increasing awareness and
technological advancements pertaining to the
treatment. The eye patches segment is estimated
to hold 35.9 share of the market in 2019, as it
is a highly preferred treatment for amblyopia in
hospitals and various eye care centers.
6- Based on end-users, the market has been divided
into hospitals pharmacies, ophthalmic clinics,
and others. The hospitals pharmacies segment is
projected to hold a dominant share of the market
during the forecast period due to easy
availability of treatment facilities.
Additionally, near ability and awareness about
hospitals and pharmacies among end-users support
significant share in the market, globally. The
ophthalmic clinics segment is expected to grow at
a substantial pace owing to the growing awareness
regarding these centers among consumers.
Moreover, increasing company focus on opening of
new ophthalmic clinics is propelling the growth
in the global amblyopia market. New and emerging
players are focusing on this segment to withstand
the competition in the global amblyopia market.
7Competitive Landscape
- Key players in the market include Amblyotech,
Good-Lite Co., Vivid Vision, Cooper Vision,
Johnson Johnson, Novartis - AG, Carl Zeiss, HOYA Corporation, Fresnel Prism
and Lens, and Hilco Vision. - These companies are considered as key players in
global amblyopia market based on their revenue,
research - development (RD) activities, regional presence,
and supply chain management system. - Key players in the market are principally engaged
in acquiring regional players to increase their
sales and footprint across the globe. For
instance, in 2019, CooperVision, Inc., acquired
Blanchard Contact Lenses, Inc., which helped the
company to expand its presence in the specialty
segment.
8Key Benefits for Industry Participants
Stakeholders
- Industry drivers, restraints, and opportunities
covered in the study - Neutral perspective on the global amblyopia
market performance - Recent industry trends and developments
- Competitive landscape strategies of key players
- Potential niche segments and regions exhibiting
promising growth covered - Historical, current, and projected market size,
in terms of value - In-depth analysis of the global amblyopia market